Chapter 10 - General advice on vigilance - Great Britain

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) provides essential guidance for producers, including manufacturers and importers, of e-cigarettes and nicotine-containing refill containers operating within Great Britain. This regulatory framework is governed by the Tobacco and Related Products Regulations 2016. The guidance outlines critical vigilance obligations to ensure public safety. Producers are required to establish robust internal systems for monitoring and collecting data on any suspected adverse health effects associated with their products. If a producer has reason to believe a product is unsafe, not of good quality, or otherwise non-compliant with legal standards, they must immediately take corrective actions. These actions include withdrawing the product from the market or initiating a recall to protect consumers. Furthermore, the MHRA must be promptly informed of any safety risks, alongside relevant local enforcement authorities. Producers are also tasked with submitting annual reports detailing sales volumes, consumer group preferences, and executive summaries of market surveys. Failure to adhere to these reporting and safety monitoring protocols constitutes a violation of the regulatory framework. These requirements aim to maintain a high standard of consumer protection and ensure that any potential health risks are identified and mitigated swiftly through a transparent and accountable reporting process.